Designer Drugs for Designer Receptors: Unlocking the Translational Potential of Chemogenetics
Overview
Authors
Affiliations
Chemogenetic techniques allow selective manipulation of neurons by activating engineered actuator proteins with otherwise inert effector molecules. A recent study (Magnus et al. Science 2019;364:eaav5282) describes the coevolution of highly potent actuator-effector pairs based on a clinically approved antismoking drug. These tools allow selective excitation or inhibition of neurons in the living brain with high specificity and no detectable side-effects.
Gonzalez-Ramos A, Berglind F, Kudlacek J, Rocha E, Melin E, Sebastiao A Gene Ther. 2024; .
PMID: 39455855 DOI: 10.1038/s41434-024-00493-7.
PET reporter systems for the brain.
Nerella S, Michaelides M, Minamimoto T, Innis R, Pike V, Eldridge M Trends Neurosci. 2023; 46(11):941-952.
PMID: 37734962 PMC: 10592100. DOI: 10.1016/j.tins.2023.08.007.